Huawei, Alibaba Deploy AI to Quickly Spot Coronavirus Cases, Useful Drugs - (Yicai Global via NewsPoints Desk)

  • Huawei Technologies, Alibaba Group and other big Chinese technology companies are providing artificial intelligence (AI) and cloud computing power to hospitals and medical research institutions to help in the diagnosis of cases caused by the novel coronavirus and to test for effective treatments, Yicai Global reported on Thursday.

  • Huawei Cloud's Enterprise and Medical Intelligence Team has used super-computing power and AI algorithms to scan 8506 drugs for multiple target proteins of the virus and millions of small molecule compounds, according to team member Qiao Nan.

  • Five drugs -- beclabuvir, saquinavir, bictegravir, lopinavir and dolutegravir --  have been identified that may be effective against the 2019-nCov virus, Qiao said, adding that, the team is now conducting cytological verification of these five antiviral drugs and pursuing clinical trials.

  • Meanwhile, Alibaba's Damo Academy provided an AI algorithm that has reduced the time needed to identify 2019-nCoV in submitted samples by several hours to half an hour.

To read more NewsPoints articles, click here.